Product image of Infectosupramox Saft (Amoxicillin Trihydrate, Potassium Clavulanate) supplied by GNH India

Infectosupramox Saft

Active Ingredient:
Amoxicillin Trihydrate, Potassium Clavulanate
Origin:
EU

Infectosupramox Saft (Amoxicillin Trihydrate, Potassium Clavulanate)

Amoxicillin Trihydrate and Potassium Clavulanate, the active ingredient in Infectosupramox Saft, is a penicillin beta‑lactam antibiotic presented as a syrup for oral use. It treats a range of bacterial infections such as acute sinusitis, otitis media, community‑acquired pneumonia, urinary tract infections and skin and soft‑tissue infections in both adults and children.

GNH India supplies Infectosupramox Saft as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Infectosupramox Saft, a combination penicillin antibiotic, is used to treat bacterial infections of the respiratory, urinary and skin systems.

  • Acute sinusitis: clears the sinus infection and reduces nasal congestion.
  • Acute otitis media: eradicates the causative bacteria and improves hearing.
  • Community‑acquired pneumonia: eliminates pulmonary pathogens and prevents complications.
  • Urinary tract infections: removes uropathogens and relieves dysuria.
  • Skin and soft‑tissue infections: treats cellulitis and other bacterial skin conditions.

How It Works

  • Amoxicillin binds to penicillin‑binding proteins, inhibiting the final stages of bacterial cell‑wall peptidoglycan synthesis, which leads to cell lysis. Potassium clavulanate is a β‑lactamase inhibitor that protects amoxicillin from enzymatic degradation by β‑lactamase‑producing organisms, extending its antibacterial spectrum against resistant strains.

Side Effects

Infectosupramox Saft may cause adverse reactions that vary in frequency and severity.

Common Side Effects

  • Diarrhea: mild to moderate loose stools.
  • Nausea: feeling of queasiness, often transient.
  • Rash: skin erythema or maculopapular eruption.
  • Taste disturbance: altered or metallic taste.

Serious or Rare Side Effects

  • Anaphylaxis: severe, potentially life‑threatening allergic reaction.
  • Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain.
  • Liver enzyme elevation: increased ALT/AST indicating hepatic stress.

Precautions & Warnings

Before prescribing Infectosupramox Saft, consider the following precautions.

  • Allergy assessment: confirm no known hypersensitivity to penicillins or β‑lactamase inhibitors.
  • Renal function: adjust dose in patients with impaired renal clearance.
  • Hepatic monitoring: perform liver function tests during prolonged therapy.
  • Pregnancy and lactation: use only if the potential benefit justifies the potential risk.
  • Store at ambient temperature: keep below 25°C, retain in the original container, and protect from moisture.

Avoid Interactions

Infectosupramox Saft can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Allopurinol: increased risk of severe skin reactions.
  • Methotrexate: heightened methotrexate toxicity.
  • Oral contraceptives: reduced hormonal efficacy, risk of breakthrough bleeding.
  • Warfarin: enhanced anticoagulant effect, monitor INR closely.

Moderate Interactions (Monitor Closely)

  • Probenecid: may raise amoxicillin plasma concentrations.
  • Antacids containing aluminum or magnesium: can decrease absorption of amoxicillin.
  • Carbapenems (e.g., imipenem): antagonistic effect, may diminish antibacterial activity.

Frequently Asked Questions

Infectosupramox Saft is a prescription oral suspension that combines amoxicillin and clavulanate to treat a variety of bacterial infections, including acute sinusitis, acute otitis media, community‑acquired pneumonia, urinary tract infections, and skin and soft‑tissue infections.

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Potassium clavulanate inhibits β‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin from degradation and extending its antibacterial spectrum.

The dose is individualized by the prescribing clinician based on the type and severity of infection, the patient’s age, weight, and renal function. No fixed regimen is provided here; the prescriber determines the appropriate amount and duration.

Safety data are limited, and the product carries an unknown pregnancy category. It should be used only when the expected benefit outweighs any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Amoxicillin alone lacks protection against β‑lactamase‑producing organisms, which can render it ineffective in certain infections. Adding potassium clavulanate broadens the spectrum, making Infectosupramox Saft effective against resistant strains that would otherwise diminish the activity of amoxicillin alone.

Store the syrup at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and discard any product that appears discoloured or has an off‑taste after the expiry date.

The medication is taken orally using a calibrated measuring device such as a syringe or dosing cup. It should be given at the intervals prescribed by the healthcare provider, usually with or without food, and the full course should be completed even if symptoms improve.

Serious adverse events include anaphylactic reactions, Clostridioides difficile‑associated colitis, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience difficulty breathing, severe rash, persistent diarrhea, or signs of liver dysfunction such as jaundice.

Individuals with a documented hypersensitivity to penicillins, β‑lactamase inhibitors, or any component of the formulation should avoid this product. Caution is also advised for patients with severe renal impairment, where dose adjustment may be required.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Amoxicillin Trihydrate, Potassium Clavulanate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT